AI brief of an SEC Form 8-K · AEHR TEST SYSTEMS (AEHR)

Aehr Test Systems posts record $33.0 million Q1 revenue, raises FY2027 outlook

Positive Impact 4 of 5 earnings Written later

Aehr Test Systems reported first quarter fiscal 2027 results for the period ended September 25, 2026, with revenue of $33.0 million, up 200% from $11.0 million a year earlier, and GAAP net income of $7.2 million, or $0.21 per diluted share, compared with a net loss of $2.1 million a year earlier. The company raised its fiscal 2027 revenue outlook to $150 million from a prior range of $130 million to $150 million, which matters to shareholders because it signals higher expected sales for the year. The filing also covers a one-month transition period ended June 26, 2026, following a change in fiscal year-end.

Key points

  • Revenue was $33.0 million, up 200% year over year from $11.0 million and up 75% sequentially
  • GAAP net income was $7.2 million, or $0.21 per diluted share, versus a GAAP net loss of $2.1 million, or $0.07 per diluted share, a year earlier
  • Fiscal 2027 revenue outlook raised to $150 million from a prior range of $130 million to $150 million; non-GAAP net income expected at least 20% of revenue
  • Bookings were $46.7 million; backlog was $100.9 million at September 25, 2026, and effective backlog was $109.3 million at November 1, 2026

The filing

CompanyAEHR TEST SYSTEMS (AEHR)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:21 PM ET
Accession number0001654954-26-009385

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.